Rabbit milk holds promise for safer HAE-drug production

01/21/2010 | FoxNews.com

Dutch biotechnology firm Pharming has developed a treatment for hereditary angioedema, called Rhucin, that is derived from milk collected from rabbits genetically modified to produce C1 inhibitor. The company plans to collect the rabbit milk on a mass scale using mini-pumping machines, providing Rhucin is approved by European regulators.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC